Here is What Hedge Funds Think About Lexicon Pharmaceuticals, Inc. (LXRX)
Is Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Lexicon Pharmaceuticals Inc. (LXRX)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Here's What Hedge Funds Think About Lexicon Pharmaceuticals, Inc. (LXRX)
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...
Hedge Fund and Insider Trading News: Bill Ackman, Jana Partners, BlueCrest Capital Management, Iqvia Holdings Inc (IQV), Twelve Seas Investment Company (TWLVU), ABIOMED, Inc. (ABMD), and More
Billionaire hedge fund manager William Ackman, whose investment assets have shrunk by more than half in the last three years, has made a second round of staff cuts and laid off three investor relations...
Hedge Fund and Insider Trading News: Paul Tudor Jones, Rob Citrone, Facebook, Inc. (FB), Christopher & Banks Co. (CBK), Lexicon Pharmaceuticals, Inc. (LXRX), and More
The 50-year-old definition of capitalism in the U.S. is due for an update because of income inequality, according to billionaire hedge fund manager and philanthropist Paul Tudor Jones.
Here's What's Next For Lexicon Pharmaceuticals, Inc. (LXRX) And Dynavax Technologies Corporation (DVAX)
Two companies have logged strong starts to the week in the biotech space so far, and both are moving on FDA driven catalysts.
Biotech Movers And Shakers: Lexicon Pharmaceuticals, Inc. (LXRX) And Neuroderm Ltd (NDRM)
Right then, it’s time to take a look at who moved during the start of this week, and what’s driving the action in the biotech sector.
Lexicon Pharmaceuticals, Inc. (LXRX): Are Hedge Funds Right About This Stock?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Two Biotechs With Bad News This Week: What Happens Now?
When things go well in biotech, it can be a great ride. When things repeatedly go well, however, it can be easy to forget how quickly, and how frequently, things don’t go to plan.
Delving Into The Lexicon Pharmaceuticals, Inc. (LXRX) Data
Lexicon Pharmaceuticals, Inc.
Do Investors Like Lexicon Pharmaceuticals, Inc. (LXRX) or Ariad Pharmaceuticals, Inc. (ARIA) More?
It is already common knowledge that individual investors do not usually have the necessary resources and ability to properly research an investment opportunity.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
